JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
1326
Summit Hotel Properties
INN
$673M
| $21.3M | 0.01% |
1,637,125
+259,819
| +19% | +$3.46M |
|
1327
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
| $21.3M | 0.01% |
326,105
+322,545
| +9,060% | +$21.9M |
|
1328
Dr. Reddy's Laboratories
RDY
$10.4B
| $21.2M | 0.01% |
1,918,690
+229,555
| +14% | +$2.53M |
|
|
GRMN
1329
Garmin
GRMN
$60B
| $21.2M | 0.01% |
481,819
+136,932
| +40% | +$6.31M |
|
1330
Raymond James Financial
RJF
$34.6B
| $21.2M | 0.01% |
532,770
+86,616
| +19% | +$3.37M |
|
1331
Allegion
ALLE
$14.3B
| $21.1M | 0.01% |
351,464
+56,743
| +19% | +$3.48M |
|
1332
Avista
AVA
$3.22B
| $21.1M | 0.01% |
688,831
-542
| -0.1% | -$17.5K |
|
1333
Franklin Resources
BEN
$17.2B
| $21.1M | 0.01% |
430,522
+28,350
| +7% | +$1.45M |
|
|
TCF
1334
DELISTED
TCF Financial Corporation
TCF
| $21M | 0.01% |
1,267,217
-561,514
| -31% | -$9.02M |
|
1335
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $21M | ﹤0.01% |
263,098
-2,164
| -0.8% | -$177K |
|
1336
Vanguard High Dividend Yield ETF
VYM
$84.1B
| $21M | ﹤0.01% |
311,844
+3,007
| +1% | +$209K |
|
|
RKUS
1337
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $21M | ﹤0.01% |
2,028,258
+11,421
| +0.6% | +$131K |
|
|
SF
1338
Stifel
SF
$12.8B
| $20.9M | ﹤0.01% |
815,940
+658,926
| +420% | +$16.2M |
|
1339
CALL
Occidental Petroleum
OXY
$59B
| $20.9M | ﹤0.01% |
269,458
+243,052
| +920% | +$19M |
|
|
SALE
1340
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $20.9M | ﹤0.01% |
1,172,413
-575,284
| -33% | -$11.1M |
|
1341
CALL
Petrobras Class A
PBR.A
$105B
| $20.9M | ﹤0.01% |
2,559,200
+2,539,600
| +12,957% | +$21.3M |
|
1342
iShares MSCI Mexico ETF
EWW
$1.91B
| $20.9M | ﹤0.01% |
365,481
+44,244
| +14% | +$2.62M |
|
1343
Cathay General Bancorp
CATY
$4.27B
| $20.8M | ﹤0.01% |
641,028
+7,774
| +1% | +$235K |
|
1344
Mativ Holdings
MATV
$729M
| $20.8M | ﹤0.01% |
521,417
+45,398
| +10% | +$1.93M |
|
|
MTOR
1345
DELISTED
MERITOR, Inc.
MTOR
| $20.8M | ﹤0.01% |
1,584,849
-247,073
| -13% | -$3.31M |
|
|
APOL
1346
DELISTED
Apollo Education Group Inc Class A
APOL
| $20.8M | ﹤0.01% |
1,614,108
-659,131
| -29% | -$11.1M |
|
|
ENBL
1347
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $20.8M | ﹤0.01% |
1,300,534
+57,492
| +5% | +$965K |
|
1348
PUT
Cheniere Energy
LNG
$55.1B
| $20.8M | ﹤0.01% |
+300,000
| New | +$22.5M |
|
|
BLUE
1349
DELISTED
bluebird bio
BLUE
| $20.8M | ﹤0.01% |
9,522
-1,433
| -13% | -$2.92M |
|
|
KATE
1350
DELISTED
Kate Spade & Company
KATE
| $20.7M | ﹤0.01% |
962,489
+37,194
| +4% | +$1.08M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.